MedTrace Logo

Study of Herbmed Plus in Ureteral Stent Discomfort

NCT01356355 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2016-01-05

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of the Ayurvedic formulation ,Herbmed Plus against placebo and anti-cholinergic drugs in relieving the ureteral stent discomfort.

Conditions

  • Ureteral Stent Discomfort

Interventions

DRUG

Herbmed plus

one capsule of herbmed plus orally twice a day with meals till the ureteral stent is in situ.

DRUG

Placebo

One capsule twice a day daily till ureteral stent in situ

DRUG

Tolterodine

One capsule twice a day daily till ureteral stent in situ

Sponsors & Collaborators

  • Dr .S.B.PATANKAR

    lead OTHER

Principal Investigators

  • SURESH B PATANKAR, MS,MCH · AMAI CHARITABLE TRUST (AMAI CHARITABLE TRUST'S ACE HOSPITAL PUNE)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-09-30
Completion
2014-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01356355 on ClinicalTrials.gov